Teladoc Health (TDOC) Expected to Announce Quarterly Earnings on Tuesday

Teladoc Health (NYSE:TDOC - Get Free Report) is expected to announce its Q2 2025 earnings results after the market closes on Tuesday, July 29th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $621.91 million for the quarter.

Teladoc Health Price Performance

Teladoc Health stock traded down $0.08 during midday trading on Friday, hitting $8.13. 3,080,487 shares of the company's stock were exchanged, compared to its average volume of 6,897,697. Teladoc Health has a 52-week low of $6.35 and a 52-week high of $15.21. The stock has a 50-day moving average price of $7.63 and a two-hundred day moving average price of $8.61. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.64 and a current ratio of 1.68. The company has a market cap of $1.43 billion, a P/E ratio of -1.37 and a beta of 1.84.

Wall Street Analysts Forecast Growth

TDOC has been the subject of several recent analyst reports. Citigroup reduced their target price on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. The Goldman Sachs Group reduced their target price on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Bank of America reduced their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th. Evercore ISI boosted their target price on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Finally, Truist Financial reduced their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research report on Tuesday, May 27th. Thirteen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $9.67.

Insider Buying and Selling

In other news, insider Fernando M. Rodrigues sold 4,174 shares of the firm's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Carlos Nueno sold 3,958 shares of the firm's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the transaction, the insider owned 17,645 shares of the company's stock, valued at approximately $121,044.70. The trade was a 18.32% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 18,656 shares of company stock worth $128,189 in the last ninety days. 0.58% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Acadian Asset Management LLC bought a new stake in shares of Teladoc Health in the first quarter worth $615,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Teladoc Health by 5.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider's stock valued at $3,566,000 after acquiring an additional 24,124 shares in the last quarter. NewEdge Advisors LLC lifted its position in shares of Teladoc Health by 1,278.7% in the first quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider's stock worth $90,000 after buying an additional 10,485 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Teladoc Health by 2.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 193,714 shares of the health services provider's stock worth $1,542,000 after buying an additional 5,235 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.